These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2676846)

  • 1. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses.
    Rossi F; Dietrich G; Kazatchkine MD
    Immunol Rev; 1989 Aug; 110():135-49. PubMed ID: 2676846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
    Rossi F; Kazatchkine MD
    J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiidiotypic suppression of autoantibodies with normal polyspecific immunoglobulins.
    Rossi F; Dietrich G; Kazatchkine MD
    Res Immunol; 1989 Jan; 140(1):19-31. PubMed ID: 2499021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
    Dietrich G; Kazatchkine MD
    J Clin Invest; 1990 Mar; 85(3):620-5. PubMed ID: 2312717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
    Dietrich G; Kaveri SV; Kazatchkine MD
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies.
    Rossi F; Guilbert B; Tonnelle C; Ternynck T; Fumoux F; Avrameas S; Kazatchkine MD
    Eur J Immunol; 1990 Sep; 20(9):2089-94. PubMed ID: 2209705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis.
    Rossi F; Jayne DR; Lockwood CM; Kazatchkine MD
    Clin Exp Immunol; 1991 Feb; 83(2):298-303. PubMed ID: 1993362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines and idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg).
    Dietrich G; Pereira P; Algiman M; Sultan Y; Kazatchkine MD
    J Autoimmun; 1990 Oct; 3(5):547-57. PubMed ID: 1701301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
    Sultan Y; Rossi F; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):828-31. PubMed ID: 3101065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin.
    Nydegger UE; Sultan Y; Kazatchkine MD
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S72-82. PubMed ID: 2477188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use.
    Caccavo D; Vaccaro F; Ferri GM; Amoroso A; Bonomo L
    J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases.
    Krause I; Hacham S; Gilburd B; Damianovitch M; Blank M; Shoenfeld Y
    Clin Immunol Immunopathol; 1995 Dec; 77(3):229-35. PubMed ID: 7586732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
    Sultan Y; Kazatchkine MD; Maisonneuve P; Nydegger UE
    Lancet; 1984 Oct; 2(8406):765-8. PubMed ID: 6148519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.
    Kenderov A; Minkova V; Mihailova D; Giltiay N; Kyurkchiev S; Kehayov I; Kazatchkine M; Kaveri S; Pashov A
    Clin Exp Immunol; 2002 Jul; 129(1):169-76. PubMed ID: 12100037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease.
    Hurez V; Kazatchkine MD; Vassilev T; Ramanathan S; Pashov A; Basuyaux B; de Kozak Y; Bellon B; Kaveri SV
    Blood; 1997 Nov; 90(10):4004-13. PubMed ID: 9354669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
    Blank M; Bashi T; Shoenfeld Y
    Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous immunoglobulins and anti-idiotypic suppression of auto-immunity].
    Jobin D; Kazatchkine M
    Rev Med Interne; 1992; 13(2):162-5. PubMed ID: 1410893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins and the regulation of autoimmunity through the immune network.
    Lacroix-Desmazes S; Mouthon L; Spalter SH; Kaveri S; Kazatchkine MD
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S9-15. PubMed ID: 8828942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.